Line 60: | Line 60: | ||
<p><b>PROCEDURE</b><br> | <p><b>PROCEDURE</b><br> | ||
− | We transformed <span class="bacterium">E. coli</span> Nissle with a <a href="https://static.igem.org/mediawiki/2017/ | + | We transformed <span class="bacterium">E. coli</span> Nissle with a <a href="https://static.igem.org/mediawiki/2017/5/55/T--ETH_Zurich--piG17-2-001.gb">regulator</a> and an <a href="https://static.igem.org/mediawiki/2017/6/66/T--ETH_Zurich--piG17-1-001.gb">actuator plasmid</a> (see figure 2), coding for constitutive expression of LuxR and Plux, sfGFP, mCherry and LuxI respectively (Figure 2).</p> |
<figure class="fig-nonfloat" style="width:400px;"> | <figure class="fig-nonfloat" style="width:400px;"> | ||
Line 92: | Line 92: | ||
<p><b>PROCEDURE</b><br> | <p><b>PROCEDURE</b><br> | ||
− | Two plasmids (<a href="https://static.igem.org/mediawiki/2017/f/fe/T--ETH_Zurich--piG17-2-004.gb"regulator</a> and actuator containing AND-gate designs <a href=https://static.igem.org/mediawiki/2017/ | + | Two plasmids (<a href="https://static.igem.org/mediawiki/2017/f/fe/T--ETH_Zurich--piG17-2-004.gb"regulator</a> and actuator containing AND-gate designs <a href="https://static.igem.org/mediawiki/2017/b/b9/T--ETH_Zurich--piG17-1-008a.gb">a</a>, <a href="https://static.igem.org/mediawiki/2017/c/cb/T--ETH_Zurich--piG17-1-008b.gb">b</a> and <a href="https://static.igem.org/mediawiki/2017/1/11/T--ETH_Zurich--piG17-1-008c.gb">c</a>) required for the AND-gate were transformed into <span class="bacterium">E. coli</span> Top 10 (Figure 4). Exponential-phase cultures were induced in microtiter plates under combinations of 8 different <a href="parts.igem.org/3OC6HSL">AHL</a> and 8 different L-lactate concentrations and measured after 5.5 hours growth in the palte. A detailed protocol is available in <a href="https://2017.igem.org/Team:ETH_Zurich/Protocols">Protocols.</a></p> |
<figure class="fig-nonfloat" style="width:400px;"> | <figure class="fig-nonfloat" style="width:400px;"> | ||
Line 131: | Line 131: | ||
<p><b>OBJECTIVE</b><br> | <p><b>OBJECTIVE</b><br> | ||
− | Characterize the behaviour of the AND-gate to populations at steady-state but varying densities. In this case, the bacteria are transformed with the <a href="https://static.igem.org/mediawiki/2017/ | + | Characterize the behaviour of the AND-gate to populations at steady-state but varying densities. In this case, the bacteria are transformed with the <a href="https://static.igem.org/mediawiki/2017/4/4a/T--ETH_Zurich--piG17-2-004.gb">regulator plasmid</a> and the actuator plasmid with designs <a href="https://static.igem.org/mediawiki/2017/1/12/T--ETH_Zurich--piG17-1-012a.gb">a</a> and <a href="https://static.igem.org/mediawiki/2017/d/d3/T--ETH_Zurich--piG17-1-012b.gb">b</a> that, additionally to the one used in the experiment above, also contained a gene for <a href="http://parts.igem.org/Part:BBa_K1897009">LuxI</a>, the enzyme that catalyzes synthesis of AHL <a href="#bib5" class="forward-ref">[5]</a>. This enables the bacteria to perform quorum sensing themselves which is the task they have to perform in tumor tissue. |
</p> | </p> | ||
Revision as of 20:24, 31 October 2017
Experiments:Tumor Sensor
Introduction
We incorporated a module into our system that would allow our engineered bacteria to autonomously decide if they are in tumor tissue or not . This decision is taken upon AND-logic integration of two inputs: AHL and lactate (Figure 1). Only if both these chemicals are present, the downstream modules are activated. To achieve such behaviour, we designed a synthetic promoter consisting of operators taken from BBa_K1847007, part of the Lactate sensing system [4] and the pLux promoter, part of the quorum sensing system. This promoter is regulated by the two proteins LldR and LuxR. LldR binds to the operators O1 and O2, whereby a loop in the DNA is formed that "hides" the sequence in between the operators from regulatory proteins. When lactate is present and binds to LldR, the protein undergoes a conformational change leading to release of the loop. When LuxR binds to AHL, it also undergoes a conformational change which leads to formation of LuxR homo-dimers that bind to the pLux sequence and recruit RNA polymerase whereby transcription is initiated. For a more thorough explanation visit the circuit page .
Initial System Design
The precise genetic design of our synthetic hybrid promoter was inspired by the work of the ETH iGEM team 2015. Based on their synthetic lactate-responsive promoter we came up with the idea to introduce pLux at the place of their constitutive promoter. Considering potential steric requirements of LuxR, the regulator of pLux, we further suspected spacing between pLux and O2 to be of importance. Thus, we designed another version with increased spacing. Additionally, we hypothesized that by including each operator site twice would result in a stronger effect of LldR.
Before we started any designing of regulators, cloning or experimentation on the tumor sensor module, we sat together with our modellers to find key parameters relevant for design and experimentation.
KEY QUESTIONS
- Based on previous work done on quorum sensing: how strongly should LuxR and LuxI be expressed?
Quick answer: Each 10 times stronger than the ones characterized here. - Similarly, what expression levels of LldP/LldR should be achieved in order to get enough sensitivity to differentiate tumor and non-tumor tissue?
Quick answer: ... - At what density of the colony under experimental conditions should the quorum sensing system be activated?
Quick answer: At an optical density (OD) of 0.05. The population density in the colonized layer in tumors would translate to an OD of about 60. Contrary to in vivo conditions though, in our experimental setup there would be no diffusion of AHL out of the system, amounting to an "overestimation" of the population density. Therefore, the tipping point of quorum sensing should be at such low ODs.
Overview of the Experiments
To build and characterize an AND-gate that would allow to differentiate between healthy and tumor tissue, we ran a sequence of experiments:
- We transformed E. Coli Nissle with plasmids containing only the quorum sensing system and let these colonies grow to different densities and evaluated their response. This way, we aimed to find the "trigger point" of the quorum sensing part of the tumor sensing module. This data could also be used by the modelleres to infer important paramters of the system and thus guide further design.
- We evaluated the response of our AND-gate designs to varying amounts of lactate and AHL. Based on this data we aimed to evaluate functionality of the rationally designed hybrid promoters and determine the design most suitable to our system's needs.
- Finally, we transformed E. Coli TOP10 with plasmids containing the whole tumor sensor system and evaluated the how the cultures behave over time under conditions corresponding to healthy and tumorous tissue. This way, we aimed at confirming the findings of the previous experiment and show that our system behaves as required for an autonomous interpretation of environmental signal.
To read more about each of these experiments, click on the buttons below. For a detailed protocol describing each experiment, visit Protocols.
Quorum Sensing End-Point Characterization
OBJECTIVE
Determine the population density at which the quorum system gets activated and provide the modellers with data to infer aLuxI, the production rate of LuxI.
PROCEDURE
We transformed E. coli Nissle with a regulator and an actuator plasmid (see figure 2), coding for constitutive expression of LuxR and Plux, sfGFP, mCherry and LuxI respectively (Figure 2).
Subsequently, we let these colonies grow to different final population densities. This was achieved by varying glucose concentrations in a defined medium. [1] Population density was assessed by measuring absorbance at 600 nm wavelength. Fluorescence emitted by sfGFP and mCherry served as a read-out of the level of activation. A detailed protocol is available in Protocols.
RESULTS
CONCLUSION
- We can modulate the density a bacterial population reaches in defined medium by varying the amount of glucose.
- The quorum sensing system shows a response to increasing population densities.
- The steep increase in fluorescence between absorbance 0.4 and 0.5 indicates the threshold for activation of the quorum sensing system to be at around 0.4. As a rule of thumb, we established that OD values are around 4 times higher than A600 values (data not shown) for absorbances around between 0.1 and 0.6 for the same sample. Thus, to fulfill the criterium given to us by the modellers (e.g. activation at an OD of 0.05) further tuning of the system is needed.
AND-gate without Quorum Sensing
OBJECTIVE
Determine the dose-response behaviour of our synthetic AND gate to the two inducer AHL and lactate. In this experiment we wanted to assess whether our designs would be capable to distinguish healthy and tumor tissue based on lactate and expected AHL concentrations.
PROCEDURE
Two plasmids ( and actuator containing AND-gate designs a, b and c) required for the AND-gate were transformed into E. coli Top 10 (Figure 4). Exponential-phase cultures were induced in microtiter plates under combinations of 8 different AHL and 8 different L-lactate concentrations and measured after 5.5 hours growth in the palte. A detailed protocol is available in Protocols.
RESULTS
All our synthetic promoters react to increasing inducer levels by increasing expression of the encoded gene. Hence, the highest level of activation coincides with the highest amounts of inducers. No activation is observed at low and intermediary concentrations of inducers and only in regimes with high amounts of inducer there is an increase in expression levels. This behaviour is consistent with our expectations.
- Design a shows a 20-fold increase at the high/high regime over the low/low regimes. In case lactate is highly concentrated and AHL is absent, there is already some activation of around 9-fold. Similarly, highly concentrted AHL alone leads to an increase in expression of around 4-fold.
- With a GFP-expression level 48-fold higher in presence of both inducers at high levels than in absence of both inducers, design b shows the strongest response to the inducers. Similar to design a, there is some activation even if only one of the two inducer is present in high amounts.
- Design c shows the smallest response to high inducer levels with activation of around 16-fold. The observation of activation in presence of high levels of only one inducer is made for this design as well.
CONCLUSIONS
- Our synthetic AND-gate promoter responds to both inputs lactate and AHL. Thus, it enables the engineered bacteria to sense the environment with regard to the inducers we chose.
- Indepently of the amount of the cognate inducer, both lactate and AHL alone at high concentrations lead to increased expression levels.
- While characterizing the MRI Imaging Module, a dose-response curve of the pLux promoter to AHL was obtained. There, it was found that the threshold for induction is around 10^(-7) M AHL. Here, this value lies around 10^-(5) M AHL. Thus, we came to realize that we cannot assume the behaviour of pLux alone to be similar to that of pLux in the hybrid promoter context. Based on this result we decided to focus more on the quorum sensing system in the hybrid promoter context rather than on tuning it independently as in figure 3.
- We hypothesize that this decrease in sensitivity is caused by reduced accessability of LuxR to the pLux promoter in the hybrid promoter context. Indeed, we were able to reproduce this effect by modelling. LINK!
- Considering that in healthy tissue lactate levels of around 1 mM were found while these values were found to be at around 5 mM in tumor tissue [2], we see that there is a large difference in activation between "healthy" lactate levels vs. "tumor" lactate levels. For all promoter designs and over all AHL concentrations, activity is increased consistently around 3 to 5 times from "healthy" to "tumor" lactate levels.
- Considering further that AHL levels in non-tumorous tissue would be low in the first days after administration of CATE to zero after 3-4 days [3], we see that also for AHL there is a difference in activation at "healthy" vs. "tumor" concentrations. Based on modelling, we assume AHL levels of
- Based on this data we conclude that our hybrid promoter allows CATE to distinguish levels of lactate and AHL in healthy tissue to those in tumor tissue.
AND-gate with Quorum Sensing
OBJECTIVE
Characterize the behaviour of the AND-gate to populations at steady-state but varying densities. In this case, the bacteria are transformed with the regulator plasmid and the actuator plasmid with designs a and b that, additionally to the one used in the experiment above, also contained a gene for LuxI, the enzyme that catalyzes synthesis of AHL [5]. This enables the bacteria to perform quorum sensing themselves which is the task they have to perform in tumor tissue.
PROCEDURE
Two plasmids required for the AND-gate were transformed into E. coli Top 10 (Figure 6). Cultures were grown over night in deep-well plates in media with varying lactate and glucose concentrations. The measurements of population density and GFP fluorescence were taken after ~16 hours on a plate reader. A detailed protocol is available under Protocols.
RESULTS
The data is very noisy and it’s hard to make general statements about this systems behaviour. Despite this, a clear trend is visible for GFP to be higher expressed under lactate concentrations similar to tumor tissue than under those resembling healthy tissue or no lactate at all. With increasing population densities this effect becomes less pronounced (Figure 7).
CONCLUSION
- Due to a lot of noise in the data, conclusions have to be drawn with caution
- Under lactate concentration mimicking tumor tissue, GFP gets stronger expressed than under lactate levels associated with healthy tissue.
- Fold-changes are around 4 for design B and 2 for design A which is considerably less than observed in Figure 5. This might be due to a somewhat different experimental setup (see Protocols) that lead to accumulation of GFP. Another explanation could be that the amounts of AHL are lower than the ones used in the experiment "AND-gate without Quorum Sensing".
References
- Contois, D. E. "Kinetics of bacterial growth: relationship between population density and specific growth rate of continuous cultures." Microbiology 21.1 (1959): 40-50. doi: 10.1099/00221287-21-1-40
- ^ Yong Wu, Yunzhou Dong, Mohammad Atefi, Yanjun Liu, Yahya Elshimali, and Jaydutt V. Vadgama, “Lactate, a Neglected Factor for Diabetes and Cancer Interaction,” Mediators of Inflammation, vol. 2016, Article ID 6456018, 12 pages, 2016. doi:10.1155/2016/6456018
- ^ Stritzker, Jochen, et al. "Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice." International journal of medical microbiology 297.3 (2007): 151-162.
- Miller, Melissa B., and Bonnie L. Bassler. "Quorum sensing in bacteria." Annual Reviews in Microbiology 55.1 (2001): 165-199. doi: 10.1146/annurev.micro.55.1.165
- Fuqua, W. Claiborne, Stephen C. Winans, and E. Peter Greenberg. "Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators." Journal of bacteriology 176.2 (1994): 269. doi: 10.1128/jb.176.2.269-275.1994 Fuqua, W. Claiborne, Stephen C. Winans, and E. Peter Greenberg. "Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators." Journal of bacteriology 176.2 (1994): 269.